New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A5248

Introduced
2/28/23  
Refer
2/28/23  
Report Pass
11/20/23  
Engrossed
12/7/23  

Caption

Regulates provision of pharmaceutical services in nursing homes.

Impact

The bill reinforces the role of pharmacists in nursing homes, requiring compliance with both federal and state laws. It also establishes an interdisciplinary pharmacy and therapeutics committee within nursing homes, which will be responsible for various aspects of medication management and oversight, ultimately contributing to improved patient safety and health outcomes. The Commissioner of Health is tasked with adopting rules and regulations to implement the provisions set forth by this legislation, ensuring that standards are maintained.

Summary

Bill A5248 introduces regulations concerning the provision of pharmaceutical services in nursing homes across New Jersey. This legislation mandates that every nursing home must have at least one consultant pharmacist along with either a provider pharmacist or a director of pharmaceutical services if the facility operates its own pharmacy. This legislative change aims to enhance the quality of pharmaceutical care provided to residents in these facilities, ensuring that it is managed by qualified professionals under appropriate oversight.

Sentiment

The sentiment regarding Bill A5248 appears to be largely supportive, reflecting a consensus on the necessity for better management of pharmaceutical services in nursing homes. Supporters argue that the bill will lead to improved medication safety and efficacy for residents. There seems to be a recognition of the importance of pharmacy services in enhancing the quality of care for vulnerable populations, particularly the elderly in long-term care facilities.

Contention

While the overall reception of Bill A5248 has been positive, some concerns may arise regarding the implementation of the regulations and the potential burden on nursing homes, especially smaller facilities that may struggle with the cost of hiring additional qualified pharmacists. The need for a designated consultant pharmacist, who must be independent of the pharmaceutical services provider, introduces complexities in staffing that must be navigated. The bill's successful passage will likely prompt discussions on the balance between regulatory oversight and operational feasibility for nursing homes.

Companion Bills

NJ S3609

Same As Regulates provision of pharmaceutical services in long-term care facilities.

Similar Bills

NJ A588

Regulates provision of pharmaceutical services in nursing homes.

NJ S3609

Regulates provision of pharmaceutical services in long-term care facilities.

NJ S1965

Regulates provision of pharmaceutical services in long-term care facilities.

UT HB0301

Medication Dispenser Amendments

VA SB788

Medical cannabis program; transition from Board of Pharmacy to Virginia Cannabis Control Authority.

VA HB1597

Medical cannabis program; transition from Board of Pharmacy to Virginia Cannabis Control Authority.

UT SB0312

Pharmacy Practice Amendments

IL HB5517

HEALTH CARE COSTS ACT